A spicamycin derivative (KRN5500) provides neuropathic pain relief in patients with advanced cancer: a placebo-controlled, proof-of-concept trial. [electronic resource]
Producer: 20120815Description: 679-93 p. digitalISSN:- 1873-6513
- Adult
- Analgesics -- therapeutic use
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Middle Aged
- Neoplasms -- complications
- Neuralgia -- diagnosis
- Pain Measurement -- drug effects
- Pilot Projects
- Placebo Effect
- Purine Nucleosides -- administration & dosage
- Spiramycin -- adverse effects
- Terminal Care -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.